0001104659-22-007844.txt : 20220126
0001104659-22-007844.hdr.sgml : 20220126
20220126163155
ACCESSION NUMBER: 0001104659-22-007844
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220124
FILED AS OF DATE: 20220126
DATE AS OF CHANGE: 20220126
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Einhorn Andrew J.
CENTRAL INDEX KEY: 0001560685
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38709
FILM NUMBER: 22558412
MAIL ADDRESS:
STREET 1: C/O MYOS CORPORATION
STREET 2: 45 HORSEHILL ROAD, SUITE 106
CITY: CEDAR KNOLLS
STATE: NJ
ZIP: 07927
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RVL Pharmaceuticals plc
CENTRAL INDEX KEY: 0001739426
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 CROSSING BOULEVARD
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
BUSINESS PHONE: 9088091300
MAIL ADDRESS:
STREET 1: 400 CROSSING BOULEVARD
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
FORMER COMPANY:
FORMER CONFORMED NAME: Osmotica Pharmaceuticals plc
DATE OF NAME CHANGE: 20180906
FORMER COMPANY:
FORMER CONFORMED NAME: Osmotica Pharmaceuticals Ltd
DATE OF NAME CHANGE: 20180502
4
1
tm223506-4_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-01-24
0
0001739426
RVL Pharmaceuticals plc
RVLP
0001560685
Einhorn Andrew J.
C/O RVL PHARMACEUTICALS PLC
400 CROSSING BOULEVARD
BRIDGEWATER
NJ
08807
0
1
0
0
Chief Financial Officer
Ordinary Shares
2022-01-24
4
F
0
9607
1.13
D
141473
D
Ordinary Shares
22852
I
By family limited liability company
The Reporting Person is the sole managing member of the limited liability company and, as a result, may be deemed to beneficially own the ordinary shares held by the limited liability company. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.
/s/ Christopher Klein, as attorney-in-fact
2022-01-26